ABL Bio doubles down on self-sustainable growth beyond licensing deals

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-07-07 17:02 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Drugs, World News
--------------------------------------------------------------------
Snippet:
ABL Bio is seeking to transform itself from a licensing-focused biotech company into a globally competitive drug developer while advancing both its oncology pipeline and proprietary platform technologies.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]